Figure 6

Cell cycle analysis of U2-OS cells transfected with scramble, miR-16, and miR-26a oligonucleotides. (a) Cell cycle profiles of U2-OS cells transfected with indicated miR oligos in the absence or presence of 0.5 μM doxorubicin. Following transfection, the cells were treated with doxorubicin for 14 h before fixing with methanol and staining with propidium iodine. (b) Graphic representation of the results shown in a